Patient-Derived Pancreatic Cancer-on-a-Chip Recapitulates the Tumor Microenvironment

The authors developed a tumor-chip device engineered to mimic the pancreatic ductal adenocarcinoma tumor microenvironment by incorporating patient-derived organoids and stromal cells, specifically pancreatic stellate cells and macrophages.